Suppr超能文献

用于治疗有或无内界膜剥除的牵引性糖尿病性黄斑水肿的玻璃体切除术。

Pars plana vitrectomy for tractional diabetic macular edema with or without internal limiting membrane peeling.

作者信息

Khattab Abdelrahman Ahmed Ali, Ahmed Mahmoud Mohammed, Hammed Abdullah Hussein

机构信息

Department of Ophthalmology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt.

出版信息

Med Hypothesis Discov Innov Ophthalmol. 2022 Dec 3;11(3):110-118. doi: 10.51329/mehdiophthal1454. eCollection 2022 Fall.

Abstract

BACKGROUND

The effectiveness of internal limiting membrane (ILM) peeling in the surgical treatment of tractional diabetic macular edema (DME), although widely examined, remains controversial. This study aimed to assess the efficacy of pars plana vitrectomy (PPV) in the management of tractional DME and to highlight any benefits of additional ILM peeling.

METHODS

This was an open-label, prospective, comparative, and interventional study that enrolled 50 eyes with tractional DME that underwent PPV and allocated each to one of two groups: group A consisted of 25 eyes that had no ILM peeling and group B consisted of 25 eyes that underwent ILM peeling. Postoperative assessments of best-corrected distance visual acuity (BCDVA) in the logarithm of minimal angle of resolution (logMAR) notation and central macular thickness (CMT) were performed at 1, 3, and 6 months postoperatively.

RESULTS

At baseline, the two groups were comparable in terms of sex ratios, phakic status, insulin use, coexistence of hypertension, and mean (standard deviation [SD]) age, BCDVA, CMT, duration of diabetes mellitus, and glycosylated hemoglobin (HbA1c) levels. In group A, the mean (SD) BCDVA improved significantly from 0.89 (0.12) logMAR preoperatively to 0.64 (0.24) logMAR (P < 0.001), and the mean (SD) CMT declined significantly from 471.28 (80.83) µm to 228.20 (26.45) µm (P < 0.001), at the 6-month postoperative assessment. Likewise, in group B, the mean (SD) BCDVA improved significantly from 0.83 (0.10) logMAR preoperatively to 0.58 (0.24) logMAR (P < 0.001), and the mean (SD) CMT decreased significantly from 496.84 (89.82) µm to 226.20 (18.04) µm (P < 0.001), after 6 months. There were no significant differences between groups A and B in the changes in BCDVA (Delta BCDVA) or CMT (Delta CMT) at 1, 3, and 6 months postoperatively with respect to the baseline values (all P > 0.05). Postoperative complications were comparable between the two groups. A significant negative correlation was detected between the preoperative HbA1c level and BCDVA improvement in all participants (r = - 0.82; P < 0.001).

CONCLUSIONS

PPV is an effective treatment for tractional DME. Additional ILM peeling was not significantly associated with functional and anatomical benefits over a short period. Long-term glycemic control plays a role in vision gain after vitrectomy in patients with diabetes. Further long-term studies are required to verify our findings.

摘要

背景

尽管广泛研究了内界膜(ILM)剥除术在牵引性糖尿病性黄斑水肿(DME)手术治疗中的有效性,但仍存在争议。本研究旨在评估玻璃体切除术(PPV)治疗牵引性DME的疗效,并强调额外进行ILM剥除的任何益处。

方法

这是一项开放标签、前瞻性、对比性和干预性研究,纳入50只患有牵引性DME且接受PPV的眼睛,并将其分为两组:A组由25只未进行ILM剥除的眼睛组成,B组由25只进行了ILM剥除的眼睛组成。术后1、3和6个月采用最小分辨角对数(logMAR)表示法评估最佳矫正远视力(BCDVA),并测量中心黄斑厚度(CMT)。

结果

基线时,两组在性别比例、晶状体状态、胰岛素使用情况、高血压并存情况以及平均(标准差[SD])年龄、BCDVA、CMT、糖尿病病程和糖化血红蛋白(HbA1c)水平方面具有可比性。在A组,术后6个月评估时,平均(SD)BCDVA从术前的0.89(0.12)logMAR显著提高至0.64(0.24)logMAR(P<0.001),平均(SD)CMT从471.28(80.83)µm显著降至228.20(26.45)µm(P<0.001)。同样,在B组,术后6个月时,平均(SD)BCDVA从术前的0.83(0.10)logMAR显著提高至0.58(0.24)logMAR(P<0.001),平均(SD)CMT从496.84(89.82)µm显著降至226.20(18.04)µm(P<0.001)。术后1、3和6个月时,A组和B组的BCDVA变化(ΔBCDVA)或CMT变化(ΔCMT)相对于基线值均无显著差异(所有P>0.05)。两组术后并发症相当。在所有参与者中,术前HbA1c水平与BCDVA改善之间存在显著负相关(r=-0.82;P<0.001)。

结论

PPV是治疗牵引性DME的有效方法。短期内,额外进行ILM剥除与功能和解剖学益处无显著关联。长期血糖控制对糖尿病患者玻璃体切除术后的视力改善有作用。需要进一步的长期研究来验证我们的发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7b3/10445315/2f14e5850068/mehdiophth-11-110-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验